MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Spinocerebellar ataxia"

  • 2017 International Congress

    Neurotological Findings in Sporadic Ataxia

    B. Zeigelboim, H. Teive, K. Kronbauer, A. Scheidt, J. Faryniuk, T. Oliveira, A. Lacerda (Curitiba, Brazil)

    Objective: To examine vestibular disorders in patients with sporadic ataxia (SA). Background: Ataxias are a heterogeneous group of neurodegenerative diseases characterized by the presence of…
  • 2017 International Congress

    Effect of Virtual Reality on Balance Rehabilitation

    B. Zeigelboim, H. Teive, G. Dos Santos, M. Severiano (Curitiba, Brazil)

    Objective: To verify the effect of a balance rehabilitation program with virtual reality (VR) in patients with SCA Background: Spinocerebellar ataxias (SCAs) constitute a group…
  • 2017 International Congress

    A comparative study between OCT in SCA3 and 10

    F. Tensini, M. Sato, N. Shiokawa, H. Teive (Curitiba, Brazil)

    Objective: To describe OCT findings in spinocerebellar ataxia (SCA) type 10, correlate it with expansion size and disease severity and compare with those of SCA3…
  • 2017 International Congress

    Quantitative evaluation of gait ataxia by triaxial accelerometers is more sensitive than SARA within 1.5 years.

    S. Shirai, I. Yabe, M. Matsushima, Y. Ito, M. Yoneyama, H. Sasaki (Sapporo, Japan)

    Objective: An appropriate biomarker for spinocerebellar degeneration (SCD) is needed. Background: Previously we reported that the average amplitude of medial-lateral of straight gait gained by…
  • 2017 International Congress

    Early diagnosis in Spinocerebellar Ataxias: Prospects for clinical alterations and ethical dilemmas during preclinical trials.

    L. Velázquez-Pérez, R. Rodríguez-Labrada, J. Rodríguez-Diaz, Y. Vazquez-Mojena, J. Medrano-Montero, A. Estupiñán-Rodríguez (Holguín, Cuba)

    Objective: To assess the acceptation level and ethical concerns for participating in early intervention approaches in Spinocerebellar Ataxia type 2 preclinical carriers and to evaluate…
  • 2017 International Congress

    TANDEM REPEATS BEYOND THE CLINICAL DIAGNOSIS IN ADCAs

    A. Srivastava, M. Faruq, S. Shakya, I. Singh, V. Swarup (New Delhi, India)

    Objective: To present observations on abnormal expansion in both allele in ADCAs. Background: Use of expansion in tandem repeats is restricted to only disease diagnosis…
  • 2017 International Congress

    Effects of TRH therapy on the prism adaptation task in patients with spinocerebellar degeneration.

    T. Shimizu, R. Hanajima, R. Tsutsumi, K. Shimizu, N. Tominaga, Y. Ugawa, K. Nishiyama (Sagamihara, Japan)

    Objective: To reveal effects of TRH therapy on the prism adaptation task in patients with spinocerebellar degeneration (SCD). Background: TRH [Thyrotropin releasing hormone (protirelin tartrate)]…
  • 2016 International Congress

    Olfaction analysis in spinocerebellar ataxia type 10 and type 3 comparing with healthy controls and PD

    M. Moscovich, A. Moro, R. Munhoz, H.G. Teive, L.S. Moryiama (Curitiba, Brazil)

    Objective: To Analyse olfaction in spinocerebellar ataxia type 10 and type 3. Background: The main clinical manifestations of spinocerebellar ataxias (SCA) result from the involvement…
  • 2016 International Congress

    Movement disorders are the common signs as the first neurological deficit in cases with spinocerebellar ataxia type 2 (SCA2)

    N. Miyaue, R. Ando, T. Iwaki, H. Yabe, N. Nishikawa, M. Nagai, H. Takashima, M. Nomoto (Ehime, Toohn City, Japan)

    Objective: We studied neurological signs in cases with SCA2 for early diagnosis. Background: SCA2 is a classification of hereditary ataxia, however, patients with SCA2 have…
  • 2016 International Congress

    Preliminary findings of MR imaging of the entire spinal cord in Friedreich’s ataxia

    K. Reetz, S. Romanzetti, I. Dogan, M.L. Macel, D. Timmann, I.A. Giordano, T. Klockgether, J.B. Schulz (Aachen, Germany)

    Objective: To evaluate abnormalities in the entire spinal cord in patients with Friedreich's ataxia (FRDA) compared to healthy controls using magnetic resonance imaging (MRI) and…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley